AGP Executive Report
Last update: 10 hours agoPharma Market Watch: Vietnam’s drug market is nearing the US$10 billion mark in 2026, with analysts pointing to ageing demographics, rising middle-class demand and expanding health insurance as key growth drivers, while investors keep an eye on major deals like Japan’s Taisho increasing its stake in DHG Pharmaceutical. Green Industry & Health-Adjacent Sustainability: Sembcorp Development says it has secured pre-certification for Vietnam’s first LEED Volume prototype for ready-built factories and warehouses, aiming for higher energy efficiency and lower indoor water use—an indirect win for healthier workplaces and lower environmental strain. Food & Nutrition Trade: Vietfood & Beverage–Propack Vietnam 2026 (Aug 6–8, SECC) returns as a major F&B and processing/packaging event, highlighting a shift toward nutrition, health and sustainability in consumer demand. Infection Control Research: A new systematic review in Zoonoses journal summarizes antimicrobial resistance and outcomes for S. suis infections across Thailand and Vietnam, reporting low overall penicillin resistance and a human mortality rate of 16%. Patient Data Interoperability: IPSCC launched an International Patient Summary Implementation Registry, a searchable global map of IPS deployments meant to speed adoption and sharing of implementation know-how. AI & Tech Sovereignty: A VNA interview argues Vietnam should pursue “open technological sovereignty,” protecting strategic tech layers while staying plugged into the global innovation ecosystem—especially for data governance and encryption capabilities.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.